What are the Challenges in Targeting Bcl-2 Proteins?
Despite the therapeutic potential, targeting Bcl-2 family proteins poses several challenges. One major issue is the development of resistance to Bcl-2 inhibitors, which can arise through mutations or compensatory upregulation of other anti-apoptotic proteins. Additionally, the redundancy and complex interplay among family members complicate the development of effective therapies.
